Prometheus Biosciences Inc Asset Turnover Ratio (RXDX), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Prometheus Biosciences Inc   (NASDAQ: RXDX)
 

Prometheus Biosciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the third quarter 2023, Prometheus Biosciences Inc 's asset turnover ratio sequentially decreased to 0.01 in the third quarter (Mar 31 2023), this is lower than usual.

Within sector 173 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2023 compared to the preceding quarter from 3154 to 3195.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RXDX Asset Turnover Ratio (Mar 31 2023)
III. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Asset Change 199.08 % 176.61 % 3.29 % -24.13 % -20.76 %
Y / Y Revenue Change -71.8 % -37.03 % -3.78 % 289.26 % 415.66 %
Asset Turnover Ratio (TTM) 0.01 0.02 0.03 0.03 0.02
RXDX's Total Ranking # 3195 # 3154 # 3179 # 3188 # 4218
Seq. Asset Change 2.38 % 148.22 % 25.61 % -6.31 % -5.31 %
Seq. Revenue Change 69.22 % -32.54 % -23.72 % -67.62 % 277.92 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 174
Healthcare Sector # 505
Overall Market # 3195

Asset Turnover Ratio Statistics
High Average Low
7.71 5.48 4.17
(Mar 31 2022)   (Mar 31 2023)




RXDX Company Profile • Back to RXDX Efficiency Comparisons • Compare RXDX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2023 Assets at quarter ending Mar 31 2023
Spyre Therapeutics Inc   0.01 $ 1.165  Millions$ 80.468  Millions
Omega Therapeutics Inc   0.01 $ 2.321  Millions$ 166.356  Millions
Clene Inc   0.01 $ 0.550  Millions$ 41.232  Millions
Oncternal Therapeutics Inc   0.01 $ 0.947  Millions$ 71.157  Millions
Q32 Bio Inc   0.01 $ 3.208  Millions$ 243.403  Millions
Insight Molecular Diagnostics Inc   0.01 $ 1.681  Millions$ 127.822  Millions
Guided Therapeutics Inc   0.01 $ 0.035  Millions$ 2.908  Millions
Century Therapeutics inc   0.01 $ 5.861  Millions$ 496.777  Millions
Crinetics Pharmaceuticals Inc   0.01 $ 4.285  Millions$ 368.200  Millions
Lyra Therapeutics Inc   0.01 $ 1.305  Millions$ 113.333  Millions
Karuna Therapeutics Inc   0.01 $ 11.291  Millions$ 1,085.367  Millions
Checkpoint Therapeutics inc   0.01 $ 0.175  Millions$ 18.222  Millions
Synlogic Inc   0.01 $ 1.110  Millions$ 119.022  Millions
Vbi Vaccines Inc  0.01 $ 1.441  Millions$ 156.930  Millions
Chinook Therapeutics Inc   0.01 $ 5.259  Millions$ 577.384  Millions
Vyne Therapeutics Inc   0.01 $ 0.398  Millions$ 44.530  Millions
Celldex Therapeutics inc   0.01 $ 3.150  Millions$ 362.360  Millions
Foxo Technologies Inc   0.01 $ 0.484  Millions$ 56.981  Millions
4d Molecular Therapeutics Inc   0.01 $ 2.208  Millions$ 272.242  Millions
Biorestorative Therapies Inc   0.01 $ 0.135  Millions$ 16.969  Millions
Prometheus Biosciences Inc   0.01 $ 3.995  Millions$ 508.848  Millions
Serina Therapeutics Inc   0.01 $ 0.039  Millions$ 5.090  Millions
Marizyme Inc   0.01 $ 0.362  Millions$ 51.246  Millions
Bluebird Bio Inc   0.01 $ 4.033  Millions$ 585.332  Millions
Astrotech Corp  0.01 $ 0.360  Millions$ 52.454  Millions
Sage Therapeutics Inc   0.01 $ 9.398  Millions$ 1,416.146  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 11.190  Millions
Inhibrx Biosciences Inc   0.01 $ 1.280  Millions$ 225.663  Millions
Traws Pharma inc   0.01 $ 0.217  Millions$ 41.572  Millions
Cue Biopharma Inc   0.01 $ 0.432  Millions$ 83.504  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.